XML 18 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities    
Net income $ 376.8 $ 345.9
Reconciliation of net income to net cash provided by operating activities:    
Depreciation and amortization 49.1 32.5
Stock-based compensation expense 35.1 28.4
CCXI gains   (59.7)
Deferred income taxes (4.2) 185.0
Changes in assets and liabilities:    
Accounts receivable (29.9) (61.9)
Other current assets 47.8 (128.3)
Other assets (14.5) (3.2)
Accounts payable and accrued liabilities (224.2) (988.6)
Deferred revenue 167.7 125.9
Unrecognized tax benefits and other non-current tax liabilities (17.9) 0.9
Other liabilities 5.7 10.7
Net cash provided by (used in) operating activities 391.5 (512.4)
Cash flows from investing activities    
Capital additions (15.0) (18.7)
Purchases of investments (50.3) (34.5)
Sales and maturities of short-term investments 41.1 76.8
Cash paid for acquisitions, net of cash acquired and equity investments   (5.0)
Cash received upon diposal of a subsidiary, net of cash transferred to purchaser 5.7  
Net cash used in investing activities (18.5) 18.6
Cash flows from financing activities    
Issuance of notes   798.5
Repayments of notes   (300.0)
Issuance of commercial paper 219.6 653.7
Repayments of commercial paper (259.6) (440.4)
Proceeds from stock-based compensation plans 28.5 22.1
Repurchase of shares related to stock-based compensation (42.0) (47.5)
Cost of treasury shares repurchased (43.4) (55.0)
Dividends (84.1) (72.6)
Dividends to noncontrolling interests (1.1) (0.2)
Debt issuance costs and related fees (0.2) (4.9)
Net cash provided (used in) by financing activities (182.3) 553.7
Effect of exchange rate changes on cash and cash equivalents 15.1 18.2
Net increase (decrease) in cash and cash equivalents 205.8 78.1
Cash and cash equivalents, beginning of the period 1,071.5 2,051.5
Cash and cash equivalents, end of the period $ 1,277.3 $ 2,129.6